BOULTHAM PARK MEDICAL PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: C83014 | LINCOLN, LN6 7SS
Showing results 151-200 of 616
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Estriol | 323 | 5,640 | £4.3K | +51.8% ▲ |
| Letrozole | 312 | 9,744 | £873 | +67.1% ▲ |
| Fluticasone furoate/vilanterol | 307 | 318 | £7.0K | +98.3% ▲ |
| 307 | 54.0K | £2.6K | +202.2% ▲ | |
| Phenytoin sodium | 303 | 9,734 | £1.6K | +275.2% ▲ |
| Perindopril erbumine | 302 | 9,727 | £690 | -43.1% ▼ |
| Prochlorperazine maleate | 302 | 9,803 | £547 | +49.4% ▲ |
| Cefalexin | 299 | 9,594 | £627 | +157.1% ▲ |
| Dorzolamide and timolol | 299 | 7,250 | £4.5K | +108.9% ▲ |
| Lorazepam | 298 | 7,846 | £2.4K | +109.1% ▲ |
| Clarithromycin | 298 | 6,508 | £1.3K | +21.5% ▲ |
| Fludrocortisone acetate | 285 | 6,348 | £918 | +170.2% ▲ |
| Fluticasone furoate | 283 | 290 | £2.0K | +46.1% ▲ |
| 280 | 98.8K | £1.6K | +6.1% ▲ | |
| Diltiazem hydrochloride | 275 | 9,118 | £1.7K | -10.5% ▼ |
| Insulin glargine | 270 | 1,407 | £12.5K | -4.9% ▼ |
| Clobetasone butyrate | 269 | 12.2K | £2.1K | +31.8% ▲ |
| Pramipexole | 266 | 10.8K | £10.8K | +170.9% ▲ |
| 265 | 31.1K | £1.4K | +22.5% ▲ | |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 260 | 284 | £12.6K | +55.5% ▲ |
| Biphasic isophane insulin | 260 | 1,745 | £7.5K | +133.1% ▲ |
| Bempedoic acid | 254 | 6,804 | £12.8K | +674.9% ▲ |
| Dulaglutide | 252 | 1,016 | £18.6K | +119.9% ▲ |
| Tadalafil | 251 | 2,084 | £451 | +47.6% ▲ |
| Beclometasone dipropionate | 250 | 283 | £815 | +16.2% ▲ |
| Baclofen | 247 | 57.2K | £1.1K | +23.3% ▲ |
| Oxybutynin | 246 | 10.7K | £2.7K | +29.1% ▲ |
| 246 | 264 | £1.5K | +4.1% ▲ | |
| Fluticasone/umeclidinium/vilanterol | 238 | 243 | £10.3K | +1.5% vs avg |
| Loratadine | 238 | 14.9K | £361 | +13.9% ▲ |
| Isophane insulin | 237 | 1,274 | £5.5K | +124.5% ▲ |
| Biphasic insulin aspart | 234 | 1,852 | £11.0K | +130.5% ▲ |
| Tolterodine | 232 | 6,686 | £1.2K | +56.0% ▲ |
| Azathioprine | 232 | 11.8K | £265 | +114.1% ▲ |
| Lercanidipine hydrochloride | 221 | 4,550 | £464 | -64.2% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 220 | 35.3K | £2.4K | +45.5% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 220 | 11.5K | £799 | +44.0% ▲ |
| Diclofenac diethyl | 219 | 23.5K | £1.4K | -38.3% ▼ |
| Carbomer 940/980 | 213 | 4,980 | £952 | +39.9% ▲ |
| Trimethoprim | 212 | 10.9K | £500 | +3.8% ▲ |
| Dexamethasone | 211 | 1,070 | £667 | +22.7% ▲ |
| Canagliflozin | 209 | 3,940 | £4.9K | +45.6% ▲ |
| Lisdexamfetamine dimesylate | 208 | 6,310 | £14.8K | +74.2% ▲ |
| Paroxetine hydrochloride | 203 | 7,377 | £554 | +8.8% ▲ |
| Sotalol hydrochloride | 201 | 12.9K | £474 | +185.8% ▲ |
| Umeclidinium bromide/vilanterol | 196 | 203 | £6.3K | +0.5% vs avg |
| Carbimazole | 192 | 4,801 | £542 | +70.0% ▲ |
| 191 | 2,025 | £825 | -23.5% ▼ | |
| Verapamil hydrochloride | 190 | 6,954 | £509 | +109.4% ▲ |
| 188 | 1,560 | £499 | -10.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.